DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q

August 2, 2017 9:36 AM

Oppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found